NasdaqCM - Nasdaq Real Time Price USD

Instil Bio, Inc. (TIL)

Compare
19.85
-2.15
(-9.77%)
At close: January 10 at 4:00:01 PM EST
19.85
0.00
(0.00%)
After hours: January 10 at 4:51:53 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
--
138.00
Operating Expense
57,431.00
87,157.00
203,291.00
155,560.00
33,782.00
Operating Income
-57,431.00
-87,157.00
-203,291.00
-155,560.00
-33,644.00
Net Non Operating Interest Income Expense
-138.00
3,657.00
1,772.00
80.00
70.00
Other Income Expense
-17,596.00
-72,587.00
-23,731.00
-1,275.00
-3,943.00
Pretax Income
-75,165.00
-156,087.00
-225,250.00
-156,755.00
-37,587.00
Tax Provision
-408.00
--
-2,073.00
39.00
151.00
Net Income Common Stockholders
-75,165.00
-156,087.00
-223,177.00
-156,794.00
-37,738.00
Diluted NI Available to Com Stockholders
-75,165.00
-156,087.00
-223,177.00
-156,794.00
-37,738.00
Basic EPS
-11.56
-24.00
-34.40
-29.60
-6.10
Diluted EPS
-11.56
-24.00
-34.40
-29.60
-6.10
Basic Average Shares
6,504.61
6,503.91
6,475.63
5,299.66
6,185.61
Diluted Average Shares
6,504.61
6,503.91
6,475.63
5,299.66
6,185.61
Total Operating Income as Reported
-74,742.00
-159,169.00
-226,458.00
-155,560.00
-33,644.00
Total Expenses
57,431.00
87,157.00
203,291.00
155,560.00
33,782.00
Net Income from Continuing & Discontinued Operation
-75,165.00
-156,087.00
-223,177.00
-156,794.00
-37,738.00
Normalized Income
-57,854.00
-84,075.00
-200,218.50
-156,794.00
-37,738.00
Interest Income
7,830.00
8,866.00
3,655.00
80.00
70.00
Interest Expense
7,968.00
5,209.00
1,883.00
--
--
Net Interest Income
-138.00
3,657.00
1,772.00
80.00
70.00
EBIT
-67,197.00
-150,878.00
-223,367.00
-156,755.00
-33,644.00
EBITDA
-63,292.00
-146,122.00
-217,380.00
-154,003.00
-33,388.00
Reconciled Depreciation
3,905.00
4,756.00
5,987.00
2,752.00
256.00
Net Income from Continuing Operation Net Minority Interest
-75,165.00
-156,087.00
-223,177.00
-156,794.00
-37,738.00
Total Unusual Items Excluding Goodwill
-17,311.00
-72,012.00
-23,167.00
--
643.00
Total Unusual Items
-17,311.00
-72,012.00
-23,167.00
--
643.00
Normalized EBITDA
-45,981.00
-74,110.00
-194,213.00
-154,003.00
-33,388.00
Tax Rate for Calcs
--
--
0.00
--
0.00
Tax Effect of Unusual Items
--
--
-208.50
--
--
12/31/2020 - 3/19/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CLRB Cellectar Biosciences, Inc.
0.2823
-9.23%
 
IPSC Century Therapeutics, Inc.
0.9900
-7.48%
 
ACHL Achilles Therapeutics plc
1.1850
-0.42%
 
KROS Keros Therapeutics, Inc.
14.56
-2.22%
 
ASMB Assembly Biosciences, Inc.
15.62
-7.79%
 
SMMT Summit Therapeutics Inc.
17.85
-5.15%
 
GLPG Galapagos NV
25.65
-8.95%
 
CTMX CytomX Therapeutics, Inc.
0.8801
-10.45%
 
OKUR OnKure Therapeutics, Inc.
7.43
-4.87%
 
JANX Janux Therapeutics, Inc.
46.76
-7.99%